Cytosorbents Corp
CTSO- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001175151
In the last 90 days, Cytosorbents Corp insiders filed 4 open-market purchases and 0 sales; 50 institutions reported holding it in 13F filings for Q2 2026, worth $6.04M in total; no superinvestor holds it.
13F holders, Q2 2021
Institutional positions in Cytosorbents Corp as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 102
- +6 vs. Q1 2021
- Shares held
- 17.5M
- +46.0K (+0.3%) vs. Q1 2021
- Total value
- $132.4M
- −$19.2M (−12.7%) vs. Q1 2021
- New holders
- 17
- 25 more added
- Sold out
- 11
- 39 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CTSO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 50 | $6.04M |
| Q1 2026 | 50 | $9.32M |
| Q4 2025 | 51 | $10.8M |
| Q3 2025 | 49 | $15.3M |
| Q2 2025 | 45 | $20.7M |
| Q1 2025 | 49 | $16.9M |
| Q4 2024 | 51 | $14.1M |
| Q3 2024 | 53 | $24.7M |
| Q2 2024 | 50 | $11.8M |
| Q1 2024 | 50 | $16.7M |
| Q4 2023 | 54 | $20.0M |
| Q3 2023 | 53 | $28.7M |
| Q2 2023 | 58 | $54.7M |
| Q1 2023 | 59 | $51.3M |
| Q4 2022 | 53 | $22.7M |
| Q3 2022 | 60 | $20.7M |
| Q2 2022 | 78 | $33.9M |
| Q1 2022 | 88 | $57.3M |
| Q4 2021 | 91 | $74.6M |
| Q3 2021 | 96 | $149.2M |
| Q2 2021 | 102 | $132.4M |
| Q1 2021 | 96 | $151.6M |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding Cytosorbents Corp; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 2,112,567 | $15.9M | 0.00% | +10,629+0.5% | Added |
| BlackRock Inc. | 2,641,166 | $19.9M | 0.00% | −187,436−6.6% | Reduced |
| AWM Investment Company, Inc. | 0 | $0 | 0.00% | −150,000−100.0% | Sold out |
| Wealth Advisory Solutions, LLC | 0 | $0 | 0.00% | −139,100−100.0% | Sold out |
| California Public Employees Retirement System | 0 | $0 | 0.00% | −83,600−100.0% | Sold out |
| MetLife Investment Management | 0 | $0 | 0.00% | −17,682−100.0% | Sold out |
| Metropolitan Life Insurance Co | 0 | $0 | 0.00% | −9,062−100.0% | Sold out |
| Eudaimonia Partners, LLC | 0 | $0 | 0.00% | −4,000−100.0% | Sold out |
| Geneos Wealth Management Inc. | 0 | $0 | 0.00% | −3,215−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −1,698−100.0% | Sold out |
| Sowell Financial Services LLC | 0 | $0 | 0.00% | −1,631−100.0% | Sold out |
| Total Clarity Wealth Management, Inc. | 0 | $0 | 0.00% | −521−100.0% | Sold out |
| ShoreHaven Wealth Partners, LLC | 0 | $0 | 0.00% | −40−100.0% | Sold out |